R-spondin-1



R-spondin-1

S1SS1R2RR2G3GG3I4II4K5KK5G6GG6K7KK7R8RR8Q9QQ9R10RR10R11RR11I12II12S13SS13A14AA14E15EE15G16GG16S17SS17Q18QQ18A19AA19C20CC20A21AA21K22KK22G23GG23C24CC24E25EE25L26LL26C27CC27S28SS28E29EE29V30VV30N31NN31G32GG32C33CC33L34LL34K35KK35C36CC36S37SS37P38PP38K39KK39L40LL40F41FF41I42II42L43LL43L44LL44E45EE45R46RR46N47NN47... and 196 more residue(s)...... and 196 more residue(s)

SMILES None
InChIKey None
Sequence SRGIKGKRQRRISAEGSQACAKGCELCSEVNGCLKCSPKLFILLERNDIRQVGVCLPSCPPGYFDARNPDMNKCIKCKIEHCEACFSHNFCTKCKEGLYLHKGRCYPACPEGSSAANGTMECSSPAQCEMSEWSPWGPCSKKQQLCGFRRGSEERTRRVLHAPVGDHAACSDTKETRRCTVRRVPCPEGQKRRKGGQGRRENANRNLARKESKEAGAGSRRRKGQQQQQQQGTVGPLTSAGPA

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

R-spondin-1

S1SS1R2RR2G3GG3I4II4K5KK5G6GG6K7KK7R8RR8Q9QQ9R10RR10R11RR11I12II12S13SS13A14AA14E15EE15G16GG16S17SS17Q18QQ18A19AA19C20CC20A21AA21K22KK22G23GG23C24CC24E25EE25L26LL26C27CC27S28SS28E29EE29V30VV30N31NN31G32GG32C33CC33L34LL34K35KK35C36CC36S37SS37P38PP38K39KK39L40LL40F41FF41I42II42L43LL43L44LL44E45EE45R46RR46N47NN47... and 196 more residue(s)...... and 196 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.